SILVERARC CAPITAL MANAGEMENT, LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
+199,312
(36.8%)
New positions
30
Sold out positions
14
Turnover %
49.9%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ABVX | 45,821 | NEW |
| RNAM | 25,157 | 216.1% |
| DNTH | 24,775 | 1388.0% |
| QURE | 23,734 | 840.4% |
| GUTS | 16,526 | 5038.4% |
| CDTX | 16,091 | 317.8% |
| KOD | 14,872 | 992.8% |
| NUVL | 14,222 | 79.1% |
| RYTM | 12,041 | 47.5% |
| COGT | 11,704 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Merus N.V. | -39,028 | -100.0% |
| VRNA | -33,888 | -100.0% |
| NBIX | -20,484 | -100.0% |
| 89bio, Inc. | -20,004 | -100.0% |
| SLNO | -17,141 | -100.0% |
| PFE | -8,347 | -100.0% |
| AKRO | -7,529 | -19.8% |
| HELIX ACQUISITION CORP II | -6,514 | -100.0% |
| Metsera, Inc. | -5,906 | -100.0% |
| ASND | -4,292 | -28.7% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
50,875
(6.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|